This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
|Yesterday’s UK 100 Leaders||Price (p)||% Chg|
|STANDARD CHARTERED PLC||521.6||5.6%|
|SMITH & NEPHEW PLC||1,568.0||5.6%|
|HARGREAVES LANSDOWN PLC||1,667.5||2.5%|
|SMURFIT KAPPA GROUP PLC||3,564.0||2.5%|
|Yesterday’s UK 100 Laggards||Price (p)||% Chg|
|NATWEST GROUP PLC||196.7||-3.4%|
|FLUTTER ENTERTAINMENT PLC-DI||15335.0||-2.8%|
|JOHNSON MATTHEY PLC||3227.0||-2.1%|
|Major World Indices||Price||% Chg||1 YEAR|
|UK 100 INDEX||6,961||0.0%||13.8%|
|DOW JONES INDUS. AVG||33,896||0.2%||37.6%|
|S&P/ASX 200 INDEX||7,082||0.3%||28.3%|
|WTI Crude Oil (Nymex)||USD/bbl.||64.92||1.66%|
|Brent Crude (ICE)||USD/bbl.||68.42||1.71%|
|Gold Spot||USD/t oz.||1,769||-0.7%|
UK 100 is called to open -10 points this morning at 6951. Calls for a muted open today come as investor sentiment looks to have taken lead from overnight sessions in Asia, The Nikkei was down 220 points at 28,834 and the Hang Seng gave back 447 points to settle at 28,856. The pullback came as China Manufacturing and Non-Manufacturing PMI for April came in at 51.1 and 54.9, respectively, well below expectations. It was a different story stateside yesterday as earnings season continued in full swing, with a beat on expectations from amazon. with the Dow Jones added 240 points to close at 34,060, while the the S&P 500 gained 28 points to trade at 4,211.
AstraZeneca expects higher H2 sales as Q1 sales and earnings beat forecasts, including $275m in COVID-19 vaccine sales. Their pretax profit jumped 72% YoY to $1.61bn (2020: $935m).
Barclays Q1 profit more than doubles as bad loans shrink. They reported a profit before tax of £2.4bn (2020: £923m) above the £1.76bn average of analysts’ forecasts. They took an impairment charge of £55m for further bad loan charges, which was much less than analysts had forecast.
Card Factory says that their performance in England and Wales since reopening has topped expectations.
CVS Group expects FY revenue to be ahead of current forecasts.
Hikma announces the US FDA approval of KLOXXADO nasal spray for the emergency treatment of opioid overdose. They also see FY generics revenue towards the top end of outlook range of $770-810m as FY outlook for the group is unchanged.
Smurfit Kappa says their underlying revenue has increased 6% YoY in Q1 to 2.27bn euros.
HSBC Upgrades Johnson and Matthey to Buy from Hold (5 Buys / 8 Holds / 3 Sells)
Societe Generale Upgrades Meggitt to Hold from Sell (6 Buys / 6 Holds / 3 Sells)
Bank Holiday Monday
Chinese Non-Manufacturing PMI
German Gross Domestic Product
EU Consumer Price Index
EU Unemployment Rate
US Personal Income
US Michigan Consumer Sentiment
Reckitt Benckiser Group
GCP Infrastructure Investments
Hipgnosis Songs Fund
Edinburgh Investment Trust
UK Commercial Property REIT
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.